1 |
Bairey Merz CN, Pepine CJ, Walsh MN, et al. Ischemia and No Obstructive Coronary Artery Disease (INOCA): developing evidence-based therapies and research agenda for the next decade [J]. Circulation, 2017, 14, 135(11): 1075-1092.
|
2 |
Waheed N, Elias-Smale S, Malas W, et al. Sex differences in non-obstructive coronary artery disease [J]. Cardiovasc Res, 2020, 116(4): 829-840.
|
3 |
Murthy VL, Naya M, Taqueti VR, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes [J]. Circulation, 2014, 129(24): 2518-2527.
|
4 |
Kono T, Uetani T, Inoue K, et al. Diagnostic accuracy of stress myocardial computed tomography perfusion imaging to detect myocardial ischemia: a comparison with coronary flow velocity reserve derived from transthoracic Doppler echocardiography [J]. J Cardiol, 2020, 76(3): 251-258.
|
5 |
Hage FG, Heo J, Franks B, et al. Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus[J]. Am Heart J, 2009, 157(4): 771-776.
|
6 |
张运, 陈韵岱, 傅向华, 等. 冠状动脉微血管疾病诊断和治疗的中国专家共识 [J]. 中国循环杂志, 2017, 32(5): 421-430.
|
7 |
Kunadian V, Chieffo A, Camici PG, et al. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with european society of cardiology working group on coronary pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group [J]. Eur Heart J, 2020, 41(37): 3504-3520.
|
8 |
Yang N, Su YF, Li WW, et al. Microcirculation function assessed by adenosine triphosphate stress myocardial contrast echocardiography and prognosis in patients with nonobstructive coronary artery disease [J]. Medicine (Baltimore), 2019, 98(27): e15990.
|
9 |
Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review [J]. J Am Coll Cardiol, 2018, 72(21): 2625-2641.
|
10 |
Sara JD, Widmer RJ, Matsuzawa Y, et al. Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease [J]. JACC Cardiovasc Interv, 2015, 8(11): 1445-1453.
|
11 |
Spartano NL, Lyass A, Larson MG, et al. Submaximal exercise systolic blood pressure and heart rate at 20 years of follow-up: correlates in the framingham heart study [J]. J Am Heart Assoc, 2016, 5(6): e002821.
|
12 |
Vashist A, Heller EN, Blum S, et al. Association of heart rate response with scan and left ventricular function on adenosine myocardial perfusion imaging [J]. Am J Cardiol, 2002, 89(2): 174-177.
|
13 |
Amanullah AM, Berman DS, Hachamovitch R, et al. Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT [J]. Am J Cardiol, 1997, 80(2): 132-137.
|
14 |
Abidov A, Hachamovitch R, Hayes SW, et al. Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study [J]. Circulation, 2003, 107(23): 2894-2899.
|
15 |
Hage FG, Dean P, Iqbal F, et al. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging [J]. J Nucl Cardiol, 2011, 18(6): 1086-1094.
|
16 |
Conradson TB, Clarke B, Dixon CM, et al. Effects of adenosine on autonomic control of heart rate in man [J]. Acta Physiol Scand, 1987, 131(4): 525-531.
|
17 |
Hage FG, Heo J, Franks B, et al. Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus [J]. Am Heart J, 2009, 157(4): 771-776.
|
18 |
Hage FG, Perry G, Heo J, et al. Blunting of the heart rate response to adenosine and regadenoson in relation to hyperglycemia and the metabolic syndrome [J]. Am J Cardiol, 2010, 105(6): 839-843.
|
19 |
Bravo PE, Hage FG, Woodham RM, et al. Heart rate response to adenosine in patients with diabetes mellitus and normal myocardial perfusion imaging [J]. Am J Cardiol, 2008, 102(8): 1103-1106.
|
20 |
Tenan MS, Brothers RM, Tweedell AJ, et al. Changes in resting heart rate variability across the menstrual cycle [J]. Psychophysiology, 2014, 51(10): 996-1004.
|
21 |
Dean J, Cruz SD, Mehta PK, et al. Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy [J]. Nat Rev Cardiol, 2015, 12(7): 406-414.
|
22 |
Agrawal S, Mehta PK, Bairey Merz CN. Cardiac syndrome X: update [J]. Heart Fail Clin, 2016, 12(1): 141-156.
|
23 |
Kaski JC. Cardiac syndrome X in women: the role of oestrogen deficiency [J]. Heart, 2006, 92 Suppl 3(Suppl 3): iii5-iii9.
|
24 |
Zaffalon Júnior JR, Viana AO, de Melo GEL, et al. The impact of sedentarism on heart rate variability (HRV) at rest and in response to mental stress in young women [J]. Physiol Rep, 2018, 6(18): e13873.
|